Skip to main content

Dr. Yang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yang's full profile

Already have an account?

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2008 - 2010
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2005 - 2008
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 2005

Publications & Presentations

PubMed

Press Mentions

  • Mersana Therapeutics Appoints Arvin Yang, M.D., Ph.D. As Senior Vice President and Chief Medical Officer
    Mersana Therapeutics Appoints Arvin Yang, M.D., Ph.D. As Senior Vice President and Chief Medical OfficerNovember 30th, 2020
  • Five-Year Survival Observed in Longest Follow-up to Date of Advanced Melanoma Patients Treated with the Combination of Opdivo (Nivolumab) and Yervoy (Ipilimumab)
    Five-Year Survival Observed in Longest Follow-up to Date of Advanced Melanoma Patients Treated with the Combination of Opdivo (Nivolumab) and Yervoy (Ipilimumab)September 28th, 2019
  • Opdivo-Yervoy Combo Delays Need for Additional Treatment in Renal Cell Carcinoma Patients, Phase 3 Data Shows
    Opdivo-Yervoy Combo Delays Need for Additional Treatment in Renal Cell Carcinoma Patients, Phase 3 Data ShowsNovember 27th, 2018
  • Join now to see all